Oruka Therapeutics
Price & Volume
Stats
See moreOpen | $102.49 |
Previous Close | $99.55 |
Day Range | $96.33-$102.51 |
52W Range | $25.23-$115.52 |
Market Cap | $6.5B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.13 |
News
See moreYahoo Finance • 12 days ago
How Halozyme, Up Nearly 90% This Year, Is Rivaling Merck And Hitting New Highs
Yahoo Finance • 12 days ago
How Halozyme, Up 80% This Year, Is Rivaling Merck And Hitting New Highs
Yahoo Finance • last month
Oruka Therapeutics' Psoriasis Treatment Maintains 'Competitive Profile' After Positive Clinical Data, UBS Says
Yahoo Finance • 3 months ago
XBI vs. FBT: Broad Biotech Exposure or Concentrated Bets?
About
CEO | Dr. Lawrence Otto Klein Ph.D. |
Address | 855 Oak Grove Avenue, Menlo Park, CA, United States, 94025 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 68 |